PHARMAFLOR
Board
1 director, last change in 2025Director
appointed by deed of 26-02-2025
term without a fixed end
listed in the 2025 annual accounts, filed on 18-08-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “L'assemblée qui nomme le ou les administrateur(s) fixe leur nombre, la durée de leur mandat et, en cas de pluralité, leurs pouvoirs. A…”deed of 26-02-2025
Mandates through the years
1 name, the dashed line is todayDirector
Boardmandate already running before its first mention
Mandates as a list
-
- Director, since before 31-12-2021
Control
Shareholder
This company
PHARMAFLOR
Equity €293,388
Profit €129,524 in 2025
Capital
- Contribution
- €50,000
- Shares
- 1,000
- Contribution per share
- €50
- Equity per share
- €293 in 2025
- Source
- 2025 annual accounts
Articles of association
deed of 26-02-2025 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Moitié cédant moitié acquéreurs au prorata, mêmes formalités si non actionnaires plein droit”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Thursday of June
Shareholders
Stated in the deed
deed of 26-02-2025 ↗
- all shares